Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 845 blog entries.

April 2026

Why Precision Medicine Needs an Enterprise Digital Pathology Backbone, Not Just a Vendor

2026-04-15T12:50:24+00:00

By Nathan Buchbinder  How Proscia’s Concentriq platform transforms fragmented workflows into a scalable, AI-ready engine for precision medicine growth. Precision medicine is the frontier of modern oncology. Precision medicine companies are processing unprecedented molecular volumes, serving distributed health system networks, and racing to deploy AI-driven diagnostics that can meaningfully improve patient [...]

Why Precision Medicine Needs an Enterprise Digital Pathology Backbone, Not Just a Vendor2026-04-15T12:50:24+00:00

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

2026-04-14T15:25:59+00:00

PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to deploy PathAI’s AISight® Dx1 Digital Pathology Platform and various AI algorithm products across the multi-site network. AISight® Dx is PathAI’s cloud native digital pathology image management system designed to support laboratory workflows, [...]

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications2026-04-14T15:25:59+00:00

Biomarker-Driven Risk Stratification Using a Non-Endoscopic Capsule Sponge Identifies Ultra-High Risk Group With 85% Likelihood of Dysplasia or Cancer

2026-04-13T08:34:52+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  A UK real-world implementation study involving 910 patients demonstrated that a simple capsule sponge test coupled with biomarker analysis can safely identify more than half of the patients with Barrett’s esophagus who could replace routine endoscopic surveillance with less invasive monitoring. According to the authors, this prospective implementation study represents a paradigm shift toward precision medicine in Barrett’s [...]

Biomarker-Driven Risk Stratification Using a Non-Endoscopic Capsule Sponge Identifies Ultra-High Risk Group With 85% Likelihood of Dysplasia or Cancer2026-04-13T08:34:52+00:00

From Research to Routine: High-Throughput Spatial Biology with ZEISS and Mindpeak

2026-08-20T09:58:50+00:00

As demand for complex biomarker analysis and precision oncology continues to grow, scaling multiplex immunofluorescence (mIF) and spatial biology into high-throughput production remains a major challenge. Fragmented workflows, manual processes, and complex image analysis pipelines often slow progress and require extensive bioinformatics expertise. In this webinar, discover how ZEISS and Mindpeak are transforming spatial biology into [...]

From Research to Routine: High-Throughput Spatial Biology with ZEISS and Mindpeak2026-08-20T09:58:50+00:00

Imagene AI Announces Collaboration with Daiichi Sankyo to Advance Multimodal Biomarker Discovery in Oncology

2026-04-13T12:50:44+00:00

Collaboration leverages Imagene’s OI Suite, powered by CanvOI and a large-scale multimodal real-world data lake, alongside Composite Continuous Scoring to strengthen biomarker-driven decisions. Imagene AI, a pioneer in multimodal AI for precision oncology, today announced a collaboration with Daiichi Sankyo (TSE: 4568) to advance biomarker discovery and response prediction in oncology drug development. Through this collaboration, [...]

Imagene AI Announces Collaboration with Daiichi Sankyo to Advance Multimodal Biomarker Discovery in Oncology2026-04-13T12:50:44+00:00

Pathology Bites: Ben Cahoon on IVDR Certification and the Future of Digital Pathology

2026-04-15T12:50:36+00:00

Following the recent CE IVDR certification for the Fusion AP platform, join us for this Pathology Bites interview, where we speak with Ben Cahoon, CEO of Techcyte, about achieving this certification. In this conversation, Ben explains what IVDR certification involves and why it represents a major regulatory shift from the previous IVDD framework. He discusses how [...]

Pathology Bites: Ben Cahoon on IVDR Certification and the Future of Digital Pathology2026-04-15T12:50:36+00:00

National AI Competition to Boost Medical Imaging Diagnostics in China

2026-04-14T15:21:11+00:00

An upcoming national competition focused on the application of artificial intelligence in medical imaging review is expected to accelerate the use of AI to improve the accuracy and efficiency of diagnostic services, authorities said on Wednesday. The competition, jointly hosted by the National Healthcare Security Administration and the government of Guangxi Zhuang autonomous region, will take [...]

National AI Competition to Boost Medical Imaging Diagnostics in China2026-04-14T15:21:11+00:00

This New Way to See Disease Will Transform Medicine. Direct to Digital Imaging in Pathology w/ Matthew Nuñez | CEO, MUSE Microscopy, Inc.

2026-04-13T13:54:43+00:00

Traditional pathology workflows rely on glass slides, complex tissue processing, and long wait times for results. But what if we could eliminate slides altogether and go straight to digital imaging? In this episode, I speak with Matthew Nuñez, CEO of MUSE Microscopy, about how direct-to-digital imaging is revolutionizing pathology by improving diagnostic speed, accuracy, and accessibility. Matthew explains how MUSE uses UV light [...]

This New Way to See Disease Will Transform Medicine. Direct to Digital Imaging in Pathology w/ Matthew Nuñez | CEO, MUSE Microscopy, Inc.2026-04-13T13:54:43+00:00

Digital Pathology Market to Expand from US$ 8.2 Bn in 2026 to US$ 16.2 Bn by 2033 | Persistence Market Research

2026-04-13T08:24:57+00:00

Digital pathology enhances diagnostics using AI, imaging, and telepathology, improving accuracy, workflow efficiency, and supporting advanced personalized care. The global digital pathology market is witnessing substantial growth, driven by the increasing demand for efficient diagnostic solutions and advancements in healthcare technologies. The market is expected to reach a value of US$ 8.2 billion in 2026 and further [...]

Digital Pathology Market to Expand from US$ 8.2 Bn in 2026 to US$ 16.2 Bn by 2033 | Persistence Market Research2026-04-13T08:24:57+00:00

AI-Powered Proteogenomics Identifies Mitochondrial Signatures as Predictors of Melanoma Recurrence and Therapy Response

2026-04-07T11:29:00+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  The Melanoma MEGA-Study, a decade-long study encompassing 1,653 patients from Hungary, integrated proteogenomics, AI-driven digital pathology, and clinical data to improve risk stratification for patients with melanoma. In an interview with Pathology News, Jeovanis Gil, PhD, one of the lead investigators of the Melanoma MEGA-Study, discussed how integrating proteogenomics, digital pathology, and AI-powered analytics can enhance our understanding of melanoma [...]

AI-Powered Proteogenomics Identifies Mitochondrial Signatures as Predictors of Melanoma Recurrence and Therapy Response2026-04-07T11:29:00+00:00
Go to Top